Use of gabapentin to treat taxane-induced myalgias.
van Deventer
H
H
Bernard
S
S
D000085:Acetates / Q000627:therapeutic use*; D000588:Amines; D000700:Analgesics / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids; D000077143:Docetaxel; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced / Q000188:drug therapy*; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives*; D010146:Pain / Q000139:chemically induced / Q000188:drug therapy*; D043823:Taxoids; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000700:Analgesics; D000972:Antineoplastic Agents, Phytogenic; D003509:Cyclohexanecarboxylic Acids; D043823:Taxoids; D000077143:Docetaxel; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D017239:Paclitaxel